Dermatology · General Practice · Oncology ·
Norwegian multidisciplinary guide addresses non-melanoma skin cancer care
A Norwegian multidisciplinary guide sets out principles for assessing and treating non-melanoma skin cancer, including basal and squamous cell carcinomas. It emphasizes appropriate primary treatment, risk stratification and coordination between primary care and specialist services.
- Multidisciplinary Norwegian guide covers non-melanoma skin cancer.
- It distinguishes low- and high-risk lesions.
- Clear-margin excision may complete treatment for low-risk lesions.
- Self-examination is the usual follow-up for low-risk lesions.
The Norwegian Plastic Surgery Association has published an interdisciplinary guide for non-melanoma skin cancer, developed by representatives from pathology, general practice, dermatology, otorhinolaryngology, oncology and plastic surgery. The document expands on a 2023 guide initially intended for plastic surgery departments. Its recommendations are based on National Comprehensive Cancer Network guidance; no patient cohort or comparative evaluation is reported in this article.
The guide distinguishes low- from high-risk lesions and outlines advantages and disadvantages of treatment options. It states that low-risk lesions with clear surgical margins are considered treated, with self-examination as the usual approach to follow-up. It also covers biopsy techniques, specimen submission to pathology and referral templates.
The article reports more than 20,000 basal cell carcinoma diagnoses and more than 3,500 other non-melanoma skin cancer cases annually in Norway. The guide aims to reduce variation in care and improve coordination across health services. The source describes the recommendations but provides no outcome data on their implementation or effects; clinicians should consult the full guide for detailed criteria and management recommendations.
In practice
The guide is intended for clinicians involved in diagnosing and treating non-melanoma skin cancer in Norway. It emphasizes distinguishing low- from high-risk lesions, and states that low-risk lesions removed with clear surgical margins are considered treated, with self-examination usually used for follow-up. These principles may support consistent care and referral across primary and specialist services. The article does not provide detailed risk criteria or evidence of patient outcomes after implementation, so clinicians should consult the full guide before applying specific management decisions.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Tidsskrift for Den norske legeforening: Tverrfaglig veileder for non-melanom hudkreft ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.